Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners Partnership will further expand Julius’ clinical trial services capabilities to advance new therapeutics. Zeist, Netherlands, November 28, 2023 -- Julius Cli...
CNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts.
Read moreJulius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic and kidney disease trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients.
Read moreUnrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.
Read moreCNS disease prevalence is rising, and available treatments for many are either minimally effective or nonexistent. CNS is one of the primary therapeutic areas where we have chosen to focus efforts.
Read moreJulius Clinical’s focused approach has created a track record of excellence that testifies to our cardio-metabolic and kidney disease trial capabilities. We have honed our scientific site networks, collaborations with leading experts, and operational resources to deliver steady streams of patients and high-quality data for clients.
Read moreUnrecognised pathogens and reemerging infectious diseases are an ongoing threat to human health in every corner of the world. We contribute to important research in this area by conducting pioneering infectious disease and vaccine trials, doing what we do best: optimizing protocols and executing streamlined trials that deliver high-quality data.
Read more
"*" indicates required fields
"*" indicates required fields
